Guanfacine Hydrochloridum Guanfacine HCl CAS 29110-48-3 API USP Standard Puritas
Manufacturer cum High puritate et stabulo Quality
Nomen chemicum: Guanfacine hydrochloridum
Synonyma: Guanfacine HCl
CAS: 29110-48-3
Guanfacine hydrochloridum α2A-adrenoceptor agonist selectivum est.Antihypertensive
API High Quality, Commercial Production
Nomen chemicum | Guanfacine Hydrochloride |
Synonyma | Guanfacine HCl |
CAS Number | 29110-48-3 |
CATTUS Number | RF-API40 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C9H10Cl3N3O |
M. Pondus | 282.55 |
Liquescens punctum | 211.0~ 215.0℃ |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba ad Off-White Crystalline pulveris |
Lepidium sativum | Absorptio infrared;HPLC |
Damnum in Siccatio | ≤0.50% |
Residere in Ignition | ≤0.10% |
Metalla gravis | ≤20ppm |
Assay | 98.0%~ 102.0% (HPLC in basi exaruit) |
Chromatographic puritas | ≥99.0% |
Test Standard | USP Standard |
Consuetudinem | Active Pharmaceutical Ingredient (API) |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
Shanghai Ruifu Chemical Co., Ltd. est primarium fabricae et elit Guanfacinae hydrochloridis (CAS: 29110-48-3) cum qualitate magna.
Guanfacinum hydrochloridum centro adrenoceptor agonist agens.Antihypertensive.Guanfacinum hydrochloridum, agens anti-hypertensivum, est agonista selectiva α2A-adrenoceptor cum Kd e 31 nM et 60-plicam selectivam supra α2B adrenoceptores ostendit.Guanfacine pressionem sanguinis systolicam et diastolicam demittit per activum systematis nervosi centralis α2A norepinephrinorum autoreceptorum, quae resultat in fluxum sympatheticum periphericum reductum et sic reductionem in sono sympathetico peripherico.Applicationes therapeuticae pro guanfacino similes sunt illis aliis centro agonistis α2-adrenergicis et methyldopae agendi.In curatione aegrorum leni ad moderandam hypertensionem efficax est sicut monotherapia.